Transnational Drug Trafficking Act of 2015

Bill: 114-s-32
Sponsor: Sen. Feinstein, Dianne [D-CA]
Introduced: 2015-01-06 in the Senate
Policy area: Crime and Law Enforcement
Subjects: Crimes against property
Drug trafficking and controlled substances
Intellectual property

Summary:
action_date: 2015-01-06
text: 

Transnational Drug Trafficking Act of 2015

 
 Amends the Controlled Substances Import and Export Act to prohibit the manufacture or distribution of a controlled substance in schedule I or II, flunitrazepam, or a listed chemical by individuals having reasonable cause to believe that such substance or chemical will be unlawfully imported into the United States or into waters within 12 miles of the U.S. coast.
 
Prohibits the manufacture or distribution of a listed chemical: (1) intending or knowing that it will be used to manufacture a controlled substance; and (2) intending, knowing, or having reasonable cause to believe that the substance will be unlawfully imported into the United States. 
 
Amends the federal criminal code to revise the prohibition against, and penalties for, intentionally trafficking in a counterfeit drug to apply to intentionally trafficking in a drug and knowingly using a counterfeit mark on or in connection with such drug.

action_date: 2015-09-17
text: 
(This measure has not been amended since it was introduced. The summary has been expanded because action occurred on the measure.)
 

Transnational Drug Trafficking Act of 2015

 
(Sec. 2) This bill amends the Controlled Substances Import and Export Act to broaden the scope of persons subject to criminal prosecution for manufacturing or distributing a controlled substance in schedule I or II, a precursor chemical, or flunitrazepam for unlawful import into the United States. The Controlled Substances Act classifies drugs, substances, and chemicals used to make drugs into one of five schedules based on the drug's medical use, potential for abuse, and risk of dependence. 
 
Current law prohibits such manufacture or distribution by a person who knows or intends that the substance or chemical will be unlawfully imported. This bill broadens the scope to also prohibit such manufacture or distribution by a person who reasonably believes that the substance or chemical will be unlawfully imported. 
 
In addition, this bill prohibits the manufacture or distribution of a precursor chemical by a person who: (1) knows or intends that the chemical will be used to manufacture a controlled substance; and (2) knows, intends, or reasonably believes that the controlled substance will be unlawfully imported into the United States. 
 
(Sec. 3) The legislation amends the federal criminal code to replace statutory references to prohibited trafficking in a "counterfeit drug" with references to prohibited trafficking in a "drug that uses a counterfeit mark on or in connection with the drug."

action_date: 2015-10-07
text: 
(This measure has not been amended since it was introduced. The expanded summary of the Senate reported version is repeated here.)
 

Transnational Drug Trafficking Act of 2015

 
(Sec. 2) This bill amends the Controlled Substances Import and Export Act to broaden the scope of persons subject to criminal prosecution for manufacturing or distributing a controlled substance in schedule I or II, a precursor chemical, or flunitrazepam for unlawful import into the United States. The Controlled Substances Act classifies drugs, substances, and chemicals used to make drugs into one of five schedules based on the drug's medical use, potential for abuse, and risk of dependence. 
 
Current law prohibits such manufacture or distribution by a person who knows or intends that the substance or chemical will be unlawfully imported. This bill broadens the scope to also prohibit such manufacture or distribution by a person who reasonably believes that the substance or chemical will be unlawfully imported. 
 
In addition, this bill prohibits the manufacture or distribution of a precursor chemical by a person who: (1) knows or intends that the chemical will be used to manufacture a controlled substance; and (2) knows, intends, or reasonably believes that the controlled substance will be unlawfully imported into the United States. 
 
(Sec. 3) The legislation amends the federal criminal code to replace statutory references to prohibited trafficking in a "counterfeit drug" with references to prohibited trafficking in a "drug that uses a counterfeit mark on or in connection with the drug."

action_date: 2016-05-10
text: 
(This measure has not been amended since it was introduced. The expanded summary of the Senate reported version is repeated here.)
 

Transnational Drug Trafficking Act of 2015

 
(Sec. 2) This bill amends the Controlled Substances Import and Export Act to broaden the scope of persons subject to criminal prosecution for manufacturing or distributing a controlled substance in schedule I or II, a precursor chemical, or flunitrazepam for unlawful import into the United States. The Controlled Substances Act classifies drugs, substances, and chemicals used to make drugs into one of five schedules based on the drug's medical use, potential for abuse, and risk of dependence. 
 
Current law prohibits such manufacture or distribution by a person who knows or intends that the substance or chemical will be unlawfully imported. This bill broadens the scope to also prohibit such manufacture or distribution by a person who reasonably believes that the substance or chemical will be unlawfully imported. 
 
In addition, this bill prohibits the manufacture or distribution of a precursor chemical by a person who: (1) knows or intends that the chemical will be used to manufacture a controlled substance; and (2) knows, intends, or reasonably believes that the controlled substance will be unlawfully imported into the United States. 
 
(Sec. 3) The legislation amends the federal criminal code to replace statutory references to prohibited trafficking in a "counterfeit drug" with references to prohibited trafficking in a "drug that uses a counterfeit mark on or in connection with the drug."

action_date: 2016-05-16
text: 
(This measure has not been amended since it was introduced. The expanded summary of the Senate reported version is repeated here.)
 

Transnational Drug Trafficking Act of 2015

 
(Sec. 2) This bill amends the Controlled Substances Import and Export Act to broaden the scope of persons subject to criminal prosecution for manufacturing or distributing a controlled substance in schedule I or II, a precursor chemical, or flunitrazepam for unlawful import into the United States. The Controlled Substances Act classifies drugs, substances, and chemicals used to make drugs into one of five schedules based on the drug's medical use, potential for abuse, and risk of dependence.
 
Current law prohibits such manufacture or distribution by a person who knows or intends that the substance or chemical will be unlawfully imported. This bill broadens the scope to also prohibit such manufacture or distribution by a person who reasonably believes that the substance or chemical will be unlawfully imported.
 
In addition, this bill prohibits the manufacture or distribution of a precursor chemical by a person who: (1) knows or intends that the chemical will be used to manufacture a controlled substance; and (2) knows, intends, or reasonably believes that the controlled substance will be unlawfully imported into the United States.
 
(Sec. 3) The legislation amends the federal criminal code to replace statutory references to prohibited trafficking in a "counterfeit drug" with references to prohibited trafficking in a "drug that uses a counterfeit mark on or in connection with the drug."


Legislative actions:
action_date: 2016-05-16
text: Became Public Law No: 114-154.
action_date: 2016-05-16
text: Became Public Law No: 114-154.
action_date: 2016-05-16
text: Signed by President.
action_date: 2016-05-16
text: Signed by President.
action_date: 2016-05-13
text: Presented to President.
action_date: 2016-05-13
text: Presented to President.
action_date: 2016-05-10
text: Motion to reconsider laid on the table Agreed to without objection.
action_date: 2016-05-10
text: On motion to suspend the rules and pass the bill Agreed to by voice vote. (text: CR H2175)
action_date: 2016-05-10
text: Passed/agreed to in House: On motion to suspend the rules and pass the bill Agreed to by voice vote.(text: CR H2175)
action_date: 2016-05-10
text: DEBATE - The House proceeded with forty minutes of debate on S. 32.
action_date: 2016-05-10
text: Considered under suspension of the rules. (consideration: CR H2175-2179)
action_date: 2016-05-10
text: Mr. Goodlatte moved to suspend the rules and pass the bill.
action_date: 2015-11-17
text: Committee on United States Senate Caucus on International Narcotics Control. Hearings held.
action_date: 2015-11-03
text: Referred to the Subcommittee on Crime, Terrorism, Homeland Security, and Investigations.
action_date: 2015-10-09
text: Referred to the Subcommittee on Health.
action_date: 2015-10-08
text: Referred to the Committee on the Judiciary, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
action_date: 2015-10-08
text: Referred to the Committee on the Judiciary, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
action_date: 2015-10-08
text: Referred to the Committee on the Judiciary, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
action_date: 2015-10-08
text: Message on Senate action sent to the House.
action_date: 2015-10-08
text: Received in the House.
action_date: 2015-10-07
text: Passed Senate without amendment by Unanimous Consent. (consideration: CR S7223; text as passed Senate: CR S7223)
action_date: 2015-10-07
text: Passed/agreed to in Senate: Passed Senate without amendment by Unanimous Consent.(consideration: CR S7223; text as passed Senate: CR S7223)
action_date: 2015-09-17
text: Placed on Senate Legislative Calendar under General Orders. Calendar No. 232.
action_date: 2015-09-17
text: Committee on the Judiciary. Reported by Senator Grassley without amendment. Without written report.
action_date: 2015-09-17
text: Committee on the Judiciary. Reported by Senator Grassley without amendment. Without written report.
action_date: 2015-09-17
text: Committee on the Judiciary. Ordered to be reported without amendment favorably.
action_date: 2015-01-13
text: Referred to the Committee on the Judiciary by unanimous consent.
action_date: 2015-01-13
text: Senate Committee on Finance discharged by Unanimous Consent.
action_date: 2015-01-13
text: Senate Committee on Finance discharged by Unanimous Consent.
action_date: 2015-01-06
text: Read twice and referred to the Committee on Finance. (Sponsor introductory remarks on measure: CR S18-19)
action_date: 2015-01-06
text: Introduced in Senate

Enacted as: number: 114-154